Skip to main content

Advertisement

Log in

Fertility Preservation for the Young Breast Cancer Patient

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The American Society of Clinical Oncology (ASCO) guidelines include incorporation of fertility preservation guidelines in the care of breast oncology patients. This study aimed to examine the baseline knowledge and preferences concerning fertility preservation among women of childbearing age with newly diagnosed breast cancer at the time of their initial visit to Memorial Sloan Kettering Cancer Center (MSKCC).

Methods

A questionnaire on reproductive history, fertility knowledge, and preservation options was administered to women 18–45 years of age with newly diagnosed breast cancer at MSKCC between May and September 2011.

Results

The inclusion criteria were met by 60 women eligible for analysis who had a median age of 40 years (range 20–45 years). The findings showed that 50 % of the women either desired children in the future or were unsure whether they wanted children, with 9 % reporting that they received information about fertility preservation options before their MSKCC visit. Women who had never been pregnant were more likely than those with prior pregnancies to consider having children in the future (p = 0.001) and to contemplate fertility preservation options both before (p = 0.001) and after (p = 0.0002) cancer treatment.

Conclusion

Early referral allows patients to take advantage of fertility preservation options while preventing delay in the initiation of systemic therapy. Referral by the breast surgical oncologist at the time of the initial visit has the potential to increase fertility knowledge because it appears that many women have not yet received fertility information at this early treatment stage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Department of Health and Human Services, Centers for Disease Control and Prevention, and the National Cancer Institute. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 19992011 Incidence and Mortality Web-Based Report, Atlanta, GA, 2014.

  2. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

    Article  CAS  PubMed  Google Scholar 

  3. Bao T, Davidson NE. Gene expression profiling of breast cancer. Adv Surg. 2008;42:249–60.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.

    Article  PubMed  Google Scholar 

  5. Toi M, Iwata H, Yamanaka T, et al. Clinical significance of the 21-gene signature (oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population. Cancer. 2010;116:3112–8.

    Article  CAS  PubMed  Google Scholar 

  6. Cooke A, Mills TA, Lavender T. “Informed and uninformed decision making”: women’s reasoning, experiences and perceptions with regard to advanced maternal age and delayed childbearing: a meta-synthesis. Int J Nurs Stud. 2010;47:1317–29.

    Article  PubMed  Google Scholar 

  7. Benzies K, Tough S, Tofflemire K, et al. Factors influencing women’s decisions about timing of motherhood. J Obstet Gynecol Neonatal Nurs. 2006;35:625–33.

    Article  PubMed  Google Scholar 

  8. Mathews TJHB. First Births to Older Women Continue to Rise. NCHS data brief, no 152. National Center for Health Statistics, Hyattsville, MD, 2014.

  9. Trivers KF, Fink AK, Partridge AH, et al. Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist. 2014;19:814–22.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ben-Aharon I, Shalgi R. What lies behind chemotherapy-induced ovarian toxicity? Reproduction. 2012;144:153–63.

    Article  CAS  PubMed  Google Scholar 

  11. Tham YL, Sexton K, Weiss H, et al. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol. 2007;30:126–32.

    Article  CAS  PubMed  Google Scholar 

  12. Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372:923–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Anderson RA, Wallace WH. Antimullerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer. Fertil Steril. 2013;99:1469–75.

    Article  CAS  PubMed  Google Scholar 

  14. Rosendahl M, Andersen CY, la Cour Freiesleben N, et al. Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age. Fertil Steril. 2010;94:156–66.

    Article  CAS  PubMed  Google Scholar 

  15. Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–83.

    Article  PubMed  Google Scholar 

  16. Ruddy KJ, Gelber SI, Tamimi RM, et al. Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014;32:1151–6.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schover LR, Rybicki LA, Martin BA, et al. Having children after cancer: a pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86:697–709.

    Article  CAS  PubMed  Google Scholar 

  18. Peate M, Meiser B, Friedlander M, et al. It’s now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer: an Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;29:1670–7.

    Article  PubMed  Google Scholar 

  19. Jukkala AM, Azuero A, McNees P, et al. Self-assessed knowledge of treatment and fertility preservation in young women with breast cancer. Fertil Steril. 2010;94:2396–8.

    Article  PubMed  Google Scholar 

  20. Vadaparampil ST, Christie J, Quinn GP, et al. A pilot study to examine patient awareness and provider discussion of the impact of cancer treatment on fertility in a registry-based sample of African American women with breast cancer. Support Care Cancer. 2012;20:2559–64.

    Article  PubMed  Google Scholar 

  21. Kasum M, Beketic-Oreskovic L, Peddi PF, et al. Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol. 2014;173:13–8.

    Article  PubMed  Google Scholar 

  22. Gorman JR, Su HI, Roberts SC, et al. Experiencing reproductive concerns as a female cancer survivor is associated with depression. Cancer. 2015;121:935–42.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710–7.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Peate M, Meiser B, Cheah BC, et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer. 2012;106:1053–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.

    Article  PubMed  Google Scholar 

  26. Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. J Clin Oncol. 2009;27:5952–7.

    Article  PubMed  Google Scholar 

  27. Canada AL, Schover LR. The psychosocial impact of interrupted childbearing in long-term female cancer survivors. Psychooncology. 2012;21:134–43.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Baynosa J, Westphal LM, Madrigrano A, et al. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. J Am Coll Surg. 2009;209:603–7.

    Article  PubMed  Google Scholar 

  29. Lee S, Ozkavukcu S, Heytens E, et al. Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol. 2010;28:4683–6.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Avis NE, Levine B, Naughton MJ, et al. Age-related longitudinal changes in depressive symptoms following breast cancer diagnosis and treatment. Breast Cancer Res Treat. 2013;139:199–206.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was funded in part through NIH/NCI Cancer Center Support Grant P30 CA008748.

Disclosures

The authors have no disclosures to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary L. Gemignani MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goldfarb, S.B., Kamer, S.A., Oppong, B.A. et al. Fertility Preservation for the Young Breast Cancer Patient. Ann Surg Oncol 23, 1530–1536 (2016). https://doi.org/10.1245/s10434-015-5036-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-5036-8

Keywords

Navigation